These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30613831)

  • 1. Engineering Human Epidermal Growth Receptor 2-Targeting Hepatitis B Virus Core Nanoparticles for siRNA Delivery
    Suffian IFM; Wang JT; Faruqu FN; Benitez J; Nishimura Y; Ogino C; Kondo A; Al-Jamal KT
    ACS Appl Nano Mater; 2018 Jul; 1(7):3269-3282. PubMed ID: 30613831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
    Mohamed Suffian IFB; Wang JT; Hodgins NO; Klippstein R; Garcia-Maya M; Brown P; Nishimura Y; Heidari H; Bals S; Sosabowski JK; Ogino C; Kondo A; Al-Jamal KT
    Biomaterials; 2017 Mar; 120():126-138. PubMed ID: 28056402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
    Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
    J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes.
    Foca A; Dhillon A; Lahlali T; Lucifora J; Salvetti A; Rivoire M; Lee A; Durantel D
    Antivir Ther; 2020; 25(3):151-162. PubMed ID: 32496211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics.
    Wang Z; Zhao S; Shi J; Meng F; Yuan J; Zhong Z
    Acta Biomater; 2022 Jan; 138():443-452. PubMed ID: 34757229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules.
    Qi S; Hoppmann S; Xu Y; Cheng Z
    Mol Imaging Biol; 2019 Oct; 21(5):907-916. PubMed ID: 30617730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
    Suffian IFBM; Al-Jamal KT
    Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.
    Zhang Y; Liu Y; Zhang B; Yin S; Li X; Zhao D; Wang W; Bi J; Su Z
    Protein Expr Purif; 2021 Feb; 178():105747. PubMed ID: 32898688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.
    Pereira S; Lee J; Rubio N; Hassan HA; Suffian IB; Wang JT; Klippstein R; Ballesteros B; Al-Jamal WT; Al-Jamal KT
    Pharm Res; 2015 Oct; 32(10):3293-308. PubMed ID: 26085038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.
    Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J
    Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal-triggered packing of lipophilic NIR dye IR780 in hepatitis B core at critical ionic strength and cargo-host ratio for improved stability and enhanced cancer phototherapy.
    Lu F; Li Z; Sheng Y; Ma Y; Yang Y; Ren Y; Su Z; Yu R; Zhang S
    Biomaterials; 2021 Sep; 276():121035. PubMed ID: 34303153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Serum Albumin and HER2-Binding Affibody Fusion Proteins for Targeted Delivery of Fatty Acid-Modified Molecules and Therapy.
    Dong D; Xia G; Li Z; Li Z
    Mol Pharm; 2016 Oct; 13(10):3370-3380. PubMed ID: 27546214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma.
    Kong J; Liu X; Jia J; Wu J; Wu N; Chen J; Fang F
    Hum Gene Ther Methods; 2015 Oct; 26(5):175-80. PubMed ID: 26356810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the first
    Honarvar H; Müller C; Cohrs S; Haller S; Westerlund K; Karlström AE; van der Meulen NP; Schibli R; Tolmachev V
    Nucl Med Biol; 2017 Feb; 45():15-21. PubMed ID: 27837664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene regulation with carbon-based siRNA conjugates for cancer therapy.
    Zhang L; Zheng W; Tang R; Wang N; Zhang W; Jiang X
    Biomaterials; 2016 Oct; 104():269-78. PubMed ID: 27472164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.